Immunization with recombinant Sao protein confers protection against Streptococcus suis infection

Clinical and Vaccine Immunology

Volumn 14, Issue 8, 2007, Pages 937-943

  Li, Yuanyi ^a   Gottschalk, Marcelo ^a   Esgleas, Miriam ^a   Lacouture, Sonia ^a   Dubreuil, J Daniel ^a   Willson, Philip ^b   Harel, Josee ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE PROTEIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN G3; QUIL A; RECOMBINANT PROTEIN; SAO PROTEIN; UNCLASSIFIED DRUG; IMMUNOGLOBULIN G; IMMUNOLOGICAL ADJUVANT; MEMBRANE PROTEIN; STREPTOCOCCUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNIZATION; MOUSE; NEUTROPHIL; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; STREPTOCOCCUS SUIS; SURVIVAL RATE; SWINE; ANIMAL; ANIMAL DISEASE; BLOOD; CLASSIFICATION; GENETICS; IMMUNOLOGY; MICROBIOLOGY; MORTALITY; SWINE DISEASE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; FEMALE; IMMUNIZATION; IMMUNOGLOBULIN G; MEMBRANE PROTEINS; MICE; RECOMBINANT PROTEINS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCAL VACCINES; STREPTOCOCCUS SUIS; SWINE; SWINE DISEASES;

EID: 35248890007     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00046-07     Document Type: Article

References (53)

1. Allison, A. C., and N. E. Byars. 1986. An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity. J. Immunol. Methods 95:157-168.
2. Arulanandam, B. P., J. M. Lynch, D. E. Briles, S. Hollingshead, and D. W. Metzger. 2001. Intranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection. Infect. Immun. 69:6718-6724.
3. Bandholtz, L., M. R. Kreuger, C. Svanholm, H. Wigzell, and M. E. Rottenberg. 2002. Adjuvant modulation of the immune responses and the outcome of infection with Chlamydia pneumoniae. Clin. Exp. Immunol. 130:393-403.
4. Berthelot-Herault, F., R. Cariolet, A. Labbe, M. Gottschalk, J. Y. Cardinal, and M. Kobisch. 2001. Experimental infection of specific pathogen free piglets with French strains of Streptococcus suis capsular type 2. Can. J. Vet. Res. 65:196-200.
5. Brazeau, C., M. Gottschalk, S. Vincelette, and B. Martineau-Doize. 1996. In vitro phagocytosis and survival of Streptococcus suis capsular type 2 inside murine macrophages. Microbiology 142:1231-1237.
6. Busque, P., R. Higgins, F. Caya, and S. Quessy. 1997. Immunization of pigs against Streptococcus suis serotype 2 infection using a live avirulent strain. Can. J. Vet. Res. 61:275-279.
7. Chabot-Roy, G., P. Willson, M. Segura, S. Lacouture, and M. Gottschalk. 2006. Phagocytosis and killing of Streptococcus suis by porcine neutrophils. Microb. Pathog. 41:21-32.
8. Charland, N., J. Harel, M. Kobisch, S. Lacasse, and M. Gottschalk. 1998. Streptococcus suis serotype 2 mutants deficient in capsular expression. Microbiology 144:325-332.
9. Chu, R. S., T. McCool, N. S. Greenspan, J. R. Schreiber, and C. V. Harding. 2000. CpG oligodeoxynucleotides act as adjuvants for pneumococcal polysaccharide-protein conjugate vaccines and enhance antipolysaccharide immunoglobulin G2a (IgG2a) and IgG3 antibodies. Infect. Immun. 68:1450-1456.
10. Constant, S. L., and K. Bottomly. 1997. Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annu. Rev. Immunol. 15:297-322.
11. Crawley, A., and B. N. Wilkie. 2003. Porcine Ig isotypes: function and molecular characteristics. Vaccine 21:2911-2922.
12. DeVelasco, E. A., H. A. Dekker, P. Antal, K. P. Jalink, J. A. van Strijp, A. F. Verheul, J. Verhoef, and H. Snippe. 1994. Adjuvant Quil A improves protection in mice and enhances opsonic capacity of antisera induced by pneumococcal polysaccharide conjugate vaccines. Vaccine 12:1419-1422.
13. Elliott, S. D., F. Clifton-Hadley, and J. Tai. 1980. Streptococcal infection in young pigs. V. An immunogenic polysaccharide from Streptococcus suis type 2 with particular reference to vaccination against streptococcal meningitis in pigs. J. Hyg. 85:275-285.
14. Galina, L., U. Vecht, H. J. Wisselink, and C. Pijoan. 1996. Prevalence of various phenotypes of Streptococcus suis isolated from swine in the USA based on the presence of muraminidase-released protein and extracellular factor. Can. J. Vet. Res. 60:72-74.
15. Golding, B., and D. E. Scott. 1995. Vaccine strategies: targeting helper T cell responses. Ann. N. Y. Acad. Sci. 754:126-137.
16. Gottschalk, M., A. Lebrun, H. Wisselink, J. D. Dubreuil, H. Smith, and U. Vecht. 1998. Production of virulence-related proteins by Canadian strains of Streptococcus suis capsular type 2. Can. J. Vet. Res. 62:75-79.
17. Gottschalk, M., and M. Segura. 2000. The pathogenesis of the meningitis caused by Streptococcus suis: the unresolved questions. Vet. Microbiol. 76:259-272.
18. Haesebrouck, F., F. Pasmans, K. Chiers, D. Maes, R. Ducatelle, and A. Decostere. 2004. Efficacy of vaccines against bacterial diseases in swine: what can we expect? Vet. Microbiol. 100:255-268.
19. Halbur, P., R. Thanawongnuwech, G. Brown, J. Kinyon, J. Roth, E. Thacker, and B. Thacker. 2000. Efficacy of antimicrobial treatments and vaccination regimens for control of porcine reproductive and respiratory syndrome virus and Streptococcus suis coinfection of nursery pigs. J. Clin. Microbiol. 38:1156-1160.
20. He, Y., R. Vemulapalli, and G. G. Schurig. 2002. Recombinant Ochrobactrum anthropi expressing Brucella abortus Cu, Zn superoxide dismutase protects mice against B. abortus infection only after switching of immune responses to Th1 type. Infect. Immun. 70:2535-2543.
21. Higgins, R., and M. Gottschalk. 2005. Streptococcal diseases, p. 769-783. In S. D. B. E. Straw, W. L. Mengeling, and D. J. Taylor (ed.), Diseases of swine, 9th ed. Iowa State University Press, Ames, IA.
22. Higgins, R., M. Gottschalk, K. R. Mittal, and M. Beaudoin. 1990. Streptococcus suis infection in swine. A sixteen month study. Can. J. Vet. Res. 54:170-173.
23. Hollingshead, S. K., V. A. Fischetti, and J. R. Scott. 1987. A highly conserved region present in transcripts encoding heterologous M proteins of group A streptococci. Infect. Immun. 55:3237-3239.
24. Hollingshead, S. K., V. A. Fischetti, and J. R. Scott. 1987. Size variation in group A streptococcal M protein is generated by homologous recombination between intragenic repeats. Mol. Gen. Genet. 207:196-203.
25. Holt, M. E., M. R. Enright, and T. J. Alexander. 1988. Immunisation of pigs with live cultures of Streptococcus suis type 2. Res. Vet. Sci. 45:349-352.
26. Jacobs, A. A., A. J. van den Berg, and P. L. Loeffen. 1996. Protection of experimentally infected pigs by suilysin, the thiol-activated haemolysin of Streptococcus suis. Vet. Rec. 139:225-228.
27. Jacques, M., M. Gottschalk, B. Foiry, and R. Higgins. 1990. Ultrastructural study of surface components of Streptococcus suis. J. Bacteriol. 172:2833-2838.
28. Jones, K. F., S. K. Hollingshead, J. R. Scott, and V. A. Fischetti. 1988. Spontaneous M6 protein size mutants of group A streptococci display variation in antigenic and opsonogenic epitopes. Proc. Natl. Acad. Sci. USA 85:8271-8275.
29. Karagouni, E. E., and L. Hadjipetrou-Kourounakis. 1990. Regulation of isotype immunoglobulin production by adjuvants in vivo. Scand. J. Immunol. 31:745-754.
30. Kenney, J. S., B. W. Hughes, M. P. Masada, and A. C. Allison. 1989. Influence of adjuvants on the quantity, affinity, isotype and epitope specificity of murine antibodies. J. Immunol. Methods 121:157-166.
31. Khan, A. Q., Q. Chen, Z. Q. Wu, J. C. Paton, and C. M. Snapper. 2005. Both innate immunity and type 1 humoral immunity to Streptococcus pneumoniae are mediated by MyD88 but differ in their relative levels of dependence on Toll-like receptor 2. Infect. Immun. 73:298-307.
32. Kobisch, M., P. Morvan, R. Cariolet, G. Benevent, and J. P. Joly. 1995. Experimental infection of SPF piglets with Streptococcus suis serotype 2. J. Rech. Porc. France 27:97-102.
33. Lachenauer, C. S., R. Creti, J. L. Michel, and L. C. Madoff. 2000. Mosaicism in the alpha-like protein genes of group B streptococci. Proc. Natl. Acad. Sci. USA 97:9630-9635.
34. Lapointe, L., S. D'Allaire, A. Lebrun, S. Lacouture, and M. Gottschalk. 2002. Antibody response to an autogenous vaccine and serologic profile for Streptococcus suis capsular type 1/2. Can. J. Vet. Res. 66:8-14.
35. Lefeber, D. J., B. Benaissa-Trouw, J. F. Vliegenthart, J. P. Kamerling, W. T. Jansen, K. Kraaijeveld, and H. Snippe. 2003. Th1-directing adjuvants increase the immunogenicity of oligosaccharide-protein conjugate vaccines related to Streptococcus pneumoniae type 3. Infect. Immun. 71:6915-6920.
36. Li, Y., G. Martinez, M. Gottschalk, S. Lacouture, P. Willson, J. D. Dubreuil, M. Jacques, and J. Harel. 2006. Identification of a surface protein of Streptococcus suis and evaluation of its immunogenic and protective capacity in pigs. Infect. Immun. 74:305-312.
37. Lindblad, E. B., M. J. Elhay, R. Silva, R. Appelberg, and P. Andersen. 1997. Adjuvant modulation of immune responses to tuberculosis subunit vaccines. Infect. Immun. 65:623-629.
38. Lun, S., J. Perez-Casal, W. Connor, and P. J. Willson. 2003. Role of suilysin in pathogenesis of Streptococcus suis capsular serotype 2. Microb. Pathog. 34:27-37.
39. Lynch, J. M., D. E. Briles, and D. W. Metzger. 2003. Increased protection against pneumococcal disease by mucosal administration of conjugate vaccine plus interleukin-12. Infect. Immun. 71:4780-4788.
40. Michaelsen, T. E., J. Kolberg, A. Aase, T. K. Herstad, and E. A. Hoiby. 2004. The four mouse IgG isotypes differ extensively in bactericidal and opsonophagocytic activity when reacting with the P1.16 epitope on the outer membrane PorA protein of Neisseria meningitidis. Scand. J. Immunol. 59:34-39.
41. Neuberger, M. S., and K. Rajewsky. 1981. Activation of mouse complement by monoclonal mouse antibodies. Eur. J. Immunol. 11:1012-1016.
42. Normile, D. 2005. Infectious diseases. WHO probes deadliness of China's pig-borne disease. Science 309:1308-1309.
43. O'Hagan, D. T., M. L. MacKichan, and M. Singh. 2001. Recent developments in adjuvants for vaccines against infectious diseases. Biomol. Eng. 18:69-85.
44. Okwumabua, O., O. Abdelmagid, and M. M. Chengappa. 1999. Hybridization analysis of the gene encoding a hemolysin (suilysin) of Streptococcus suis type 2: evidence for the absence of the gene in some isolates. FEMS Microbiol. Lett. 181:113-121.
45. Smith, H. E., F. H. Reek, U. Vecht, A. L. Gielkens, and M. A. Smits. 1993. Repeats in an extracellular protein of weakly pathogenic strains of Streptococcus suis type 2 are absent in pathogenic strains. Infect. Immun. 61:3318-3326.
46. Staats, J. J., I. Feder, O. Okwumabua, and M. M. Chengappa. 1997. Streptococcus suis: past and present. Vet. Res. Commun. 21:381-407.
47. Stevens, T. L., A. Bossie, V. M. Sanders, R. Fernandez-Botran, R. L. Coffman, T. R. Mosmann, and E. S. Vitetta. 1988. Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature 334:255-258.
48. Unkeless, J. C., E. Scigliano, and V. H. Freedman. 1988. Structure and function of human and murine receptors for IgG. Annu. Rev. Immunol. 6:251-281.
49. Vecht, U., H. J. Wisselink, N. Stockhofe-Zurwieden, and H. E. Smith. 1996. Characterization of virulence of the Streptococcus suis serotype 2 reference strain Henrichsen S 735 in newborn gnotobiotic pigs. Vet. Microbiol. 51:125-136.
50. Verheul, A. F., J. A. Van Gaans, E. J. Wiertz, H. Snippe, J. Verhoef, and J. T. Poolman. 1993. Meningococcal lipopolysaccharide (LPS)-derived oligosaccharide-protein conjugates evoke outer membrane protein- but not LPS-specific bactericidal antibodies in mice: influence of adjuvants. Infect. Immun. 61:187-196.
51. Wang, P., K. Nakamura, Y. Mimura, K. Takeo, T. Tanaka, and M. Fujimoto. 1996. Immune response to different doses of a hapten of fluorescein isothiocyanate analyzed by two-dimensional affinity electrophoresis. Electrophoresis 17:1273-1279.
52. Wisselink, H. J., N. Stockhofe-Zurwieden, L. A. Hilgers, and H. E. Smith. 2002. Assessment of protective efficacy of live and killed vaccines based on a non-encapsulated mutant of Streptococcus suis serotype 2. Vet. Microbiol. 84:155-168.
53. Wisselink, H. J., U. Vecht, N. Stockhofe-Zurwieden, and H. E. Smith. 2001. Protection of pigs against challenge with virulent Streptococcus suis serotype 2 strains by a muramidase-released protein and extracellular factor vaccine. Vet. Rec. 148:473-477.